Genetic Susceptibility to Primary Intracerebral Haemorrhage

Genetic Susceptibility to Primary Intracerebral Haemorrhage

European Neurological Review, 2009;4(1):44-8

dots

Abstract
Primary intracerebral haemorrhage (PICH) originates from the spontaneous rupture of cerebral arteries as a result of chronic degenerative alterations. Although the aetiology of PICH has not been fully elucidated, it may be the result of an interaction between genetic and environmental risk factors. Several genetic association studies have been conducted in patients with PICH with both positive and negative results. Most of them investigated the role of mutations in genes affecting the lipid metabolism, the coagulation processes, the inflammation and the regulation of blood pressure. In this article we briefly discuss the majority of these studies reporting the susceptibility genes that have been implicated in PICH.

Keywords Primary intracranial haemorrhage (PICH), genetics, association studies, polymorphism

Disclosure: The authors have no conflicts of interest to declare.
Received: 3 October 2008 Accepted: 23 February 2009
Correspondence: Georgios M Hadjigeorgiou, Laboratory of Neurogenetics, Department of Neurology, School of Medicine, University of Thessaly, Greece. E: gmhadji@med.uth.gr

Primary intracerebral haemorrhage (PICH) originates from the spontaneous rupture of small arteries as a result of chronic degenerative changes due to chronic hypertension or amyloid angiopathy.1 Although environmental factors are important, there is accumulating evidence that genetic elements also contribute to the pathogenesis of PICH.2,3 In an epidemiological study, familial clustering of PICH was noticed, especially when involving deep brain structures, indicating genetic predisposition to cerebral haemorrhage.4 Increased incidence of intracerebral haemorrhage in specific animal models also provided additional evidence for the existence of susceptibility genes.5 The importance of genetic factors was unequivocally demonstrated with the identification of causative mutations in monogenic cases of familial intracerebral haemorrhage. Furthermore, several association studies have suggested the presence of susceptibility genes that predispose to PICH (see Table 1). In t his article we briefly discuss the current state of knowledge regarding the known major and susceptibility genes that have been implicated in PICH.


Familial Cases

Familial Cerebral Amyloid Angiopathy

Cerebral amyloid angiopathy (CAA) is caused by the deposition of amyloid in the small and medium-sized cortical and leptomeningeal arteries leading to intracerebral haemorrhage, ischaemic infarction or dementia. Amyloid is caused by the aggregation of β-amyloid peptide (Aβ) and other proteins, promoting vasculopathic changes such as fibrinoid necrosis and microaneurysms. Aβ peptide is formed by the proteolytic fragmentation of amyloid precursor protein. Amyloid formation has also been reported in familial cases of CAA caused by mutations in the cystatin C gene,6,7 the transthyretin gene8–12 or the BRI gene.13,14 The clinical presentation of these familial cases includes dementia, vascular cognitive decline and PICH. PICH has also been reported in a member of a Volga-German family with Alzheimer’s disease and a mutation in the presenilin-2 gene.15 Recently, a novel mutation in presenilin-1 gene was lso associated with early-onset dementia of Alzheimer type and lobar PICH.16 However, most familial cases of CAA and PICH are caused by mutations in the amyloid precursor protein. Of note, these mutations are located in the Aβ segment of the amyloid precursor protein, whereas mutations in the flanking regions cause Alzheimer’s disease or ischaemic stroke. PICH has been documented in Flemish,17 Dutch,18 Arctic,19 Iowan20 and Italian21 CAA families. Recently, duplication of the amyloid precursor protein gene was reported to be the cause of familial CAA presenting with dementia and PICH.22,23



To read full article please click here.

Keywords:
Primary intracranial haemorrhage (PICH), genetics, association studies, polymorphism, intracranial haemorrhage stroke, spntaneous intracranial hemorrhage, cerebral brain haemorrhage, genetic polymorphism, gene polymorphism, polymorphism dna, Cerebral Amyloid Angiopathy, Cerebral Amyloid Angiopathy, Cerebral Amyloid Angiopathy pathology, Cerebral Amyloid Angiopathy genetics, Cerebral Amyloid Angiopathy metabolism, Cerebral Amyloid Angiopathy etiology,

References:
  1. Qureshi AI, Tuhrim S, Broderick JP, et al., N Engl J Med, 2001;344:1450–60.
  2. Woo D, Sauerbeck LR, Kissela BM, et al., Stroke, 2002;33:1190–95.
  3. Rost NS, Greenberg SM, Rosand J, Stroke, 2008;39:2166–73.
  4. Alberts MJ, McCarron MO, Hoffmann KL, et al., Neuroepidemiology, 2002;21:18–21.
  5. Iida S, Baumbach GL, Lavoie JL, et al., Stroke, 2005;36:1253–8.
  6. Palsdottir A, Abrahamson M, Thorsteinsson L, et al., Lancet, 1988;2:603–4.
  7. Levy E, Lopez-Otin C, Ghiso J, et al., J Exp Med, 1989;169: 1771–8.
  8. Vidal R, Garzuly F, Budka H, et al., Am J Pathol, 1996;148: 361–6.
  9. Herrick MK, DeBruyne K, Horoupian DS, et al., Neurology, 1996;47:988–92.
  10. Petersen RB, Goren H, Cohen M, et al., Ann Neurol, 1997;41:307–13.
  11. Mascalchi M, Salvi F, Pirini MG, et al., Neurology, 1999;53: 1498–1503.
  12. Brett M, Persey MR, Reilly MM, et al., Brain, 1999;122:183–90.
  13. Vidal R, Frangione B, Rostagno A, et al., Nature, 1999;399: 776–81.
  14. Mead S, James-Galton M, Revesz T, et al., Brain, 2000;123 (Pt 5):975–91.
  15. Nochlin D, Bird TD, Nemens EJ, et al., Ann Neurol, 1998;43: 131–5.
  16. Sanchez-Valle R, Llado A, Ezquerra M, et al., Eur J Neurol, 2007;14:1409–12.
  17. Hendriks L, van Duijn CM, Cras P, et al., Nat Genet, 1992;1: 218–21.
  18. Levy E, Carman MD, Fernandez-Madrid IJ, et al., Science, 1990;248:1124–6.
  19. Nilsberth C, Forsell C, Axelman K, Soc Neurosci Abstr, 1999;25:297.
  20. Grabowski TJ, Cho HS, Vonsattel JP, et al., Ann Neurol, 2001;49:697–705.
  21. Tagliavini F, Rossi G, Padovani A, Alzh Reports, 1999;2:S28.
  22. Rovelet-Lecrux A, Frebourg T, Tuominen H, et al., J Neurol Neurosurg Psychiatry, 2007;78:1158–9.
  23. Cabrejo L, Guyant-Marechal L, Laquerriere A, et al., Brain, 2006;129:2966–76.
  24. Gould DB, Phalan FC, Breedveld GJ, et al., Science, 2005;308:1167–71.
  25. Gould DB, Phalan FC, van Mil SE, et al., N Engl J Med, 2006;354:1489–96.
  26. Breedveld G, de Coo IF, Lequin MH, et al., J Med Genet, 2006;43:490–95.
  27. Vahedi K, Kubis N, Boukobza M, et al., Stroke, 2007;38: 1461–4.
  28. van der Knaap MS, Smit LM, Barkhof F, et al., Ann Neurol, 2006;59:504–11.
  29. Joutel A, Corpechot C, Ducros A, et al., Nature, 1996;383: 707–10.
  30. Lesnik Oberstein SA, van den Boom R, van Buchem MA, et al., Neurology, 2001;57:1066–70.
  31. Choi JC, Kang SY, Kang J H, et al., Neurology, 2006;67:2042–4.
  32. Nicoll J A, Burnett C, Love S, et al., Ann Neurol, 1997;41: 716–21.
  33. Greenberg SM, Vonsattel JP, Segal AZ, et al., Neurology, 1998;50:961–5.
  34. McCarron MO, Nicoll JA, Neurosci Lett, 1998;247:45–8.
  35. Greenberg SM, Rebeck GW, Vonsattel JP, et al., Ann Neurol, 1995;38:254–9.
  36. Premkumar DR, Cohen DL, Hedera P, et al., Am J Pathol, 1996;148:2083–95.
  37. Greenberg SM, Briggs ME, Hyman BT, et al., Stroke, 1996;27:1333–7.
  38. Rosand J, Hylek EM, O’Donnell HC, et al., Neurology, 2000;55:947–51.
  39. O’Donnell HC, Rosand J, Knudsen KA, et al., N Engl J Med, 2000;342:240–45.
  40. Alberts MJ, Graffagnino C, McClenny C, et al., Lancet, 1995;346:575.
  41. Garcia C, Pinho e Melo T, Rocha L, et al., J Neurol, 1999;246: 830–34.
  42. Yamada M, Itoh Y, Suematsu N, et al., Ann Neurol, 1996;39: 683–4.
  43. Chowdhury AH, Yokoyama T, Kokubo Y, et al., J Epidemiol, 2001;11:131–8.
  44. McCarron M, Muir KW, Weir CJ, et al., Stroke, 1998;29:1882–7.
  45. Catto AJ, McCormack LJ, Mansfield MW, et al., Acta Neurol Scand, 2000;101:399–404.
  46. Sudlow C, Martinez Gonzalez NA, Kim J, et al., Stroke, 2006;37:364–70.
  47. Wang Y, Zhang W, et al., Circulation, 2006;113:1615–21.
  48. Yamada Y, Metoki N, Yoshida H, et al., Arterioscler Thromb Vasc Biol, 2006;26:1920–25.
  49. Strand M, Soderstrom I, Wiklund PG, et al., Cerebrovasc Dis, 2007;24:418–25.
  50. Alberts MJ, Davis JP, Graffagnino C, et al., Ann Neurol, 1997;41:683–6.
  51. Slowik A, Turaj W, Dziedzic T, et al., Neurology, 2004;63:359–61.
  52. Catto A, Carter AM, Barrett JH, et al., Stroke, 1996;27:435–40.
  53. Obach V, Revilla M, Vila N, et al., Stroke, 2001;32:2588–91.
  54. Fu Y, Xie R, Wang Y, et al., Zhonghua Yi Xue Za Zhi, 2002;82: 915–17.
  55. Pera J, Slowik A, Dziedzic T, et al., Stroke, 2006;37:906–7.
  56. Dardiotis E, Hadjigeorgiou G M, Dardioti M, et al., Eur Neurol, 2008;59:307–14.
  57. Sun L, Li Z, Zhang H, et al., Stroke, 2003;34:1617–22.
  58. Xia J, Yang QD, Yang QM, et al., Cerebrovasc Dis, 2004;17: 197–203.
  59. Iniesta J A, Corral J, Gonzalez-Conejero R, et al., Cerebrovasc Dis, 2003;15:51–5.
  60. Yoshida H, Imaizumi T, Fujimoto K, et al., Thromb Haemost, 1998;80:372–5.
  61. Catto AJ, Kohler HP, Bannan S, et al., Stroke, 1998;29: 813–16.
  62. Gemmati D, Serino ML, Ongaro A, et al., Am J Hematol, 2001;67:183–8.
  63. Corral J, Iniesta J A, Gonzalez-Conejero R, et al., Blood, 2001;97:2979–82.
  64. Endler G, Funk M, et al., Br J Haematol, 2003;120:310–14.
  65. Corral J, Iniesta J A, Gonzalez-Conejero R, et al., Hematol J, 2000;1:269–73.
  66. Reiner AP, Schwartz SM, Frank MB, et al., Stroke, 2001;32: 2580–86.
  67. Strand M, Soderstrom I, Wiklund PG, et al., Cerebrovasc Dis, 2007;24:500–508.
  68. Navarro-Nunez L, Lozano ML, Rivera J, et al., Haematologica, 2007;92:513–18.
  69. Xu H W, Yuan N, Zhao Z, et al., Cerebrovasc Dis, 2008;25: 87–94.
  70. Obach V, Munoz X, et al., Thromb Haemost, 2006;95:1040–41.
  71. McCarron MO, Stewart J, McCarron P, et al., Stroke, 2003;34:e193–5.
  72. Li Z, Sun L, Zhang H, et al., Stroke, 2003;34:2085–90.
  73. Greisenegger S, Weber M, Funk M, et al., Eur J Neurol, 2007;14:1098–1101.
  74. Munoz X, Obach V, Hurtado B, et al., Thromb Haemost, 2007;98:406–12.
  75. Kokubo Y, Chowdhury AH, Date C, et al., Stroke, 2000;31:1299–1306.
  76. Martinez-Gonzalez NA, Sudlow CL, J Neurol Neurosurg Psychiatry, 2006;77:1329–35.
  77. Vernooij MW, van der Lugt A, Ikram MA, et al., Neurology, 2008;70:1208–14.
  78. Vila N, Obach V, Revilla M, et al., Stroke, 2000;31:2103–5.
  79. Cho KH, Kim BC, Kim MK, et al., J Korean Med Sci, 2002;17: 249–53.

Copyright® 2012 Touch Group PLC. All rights reserved.
Touch Neurology is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations.